Snapshot from Sep 11, 2026 at 07:00 UTC. For live data and tracking: View Live
Business product launch

Humanity Biological Age US Launch

Analysis based on 7 articles · First reported Aug 25, 2026 · Last updated Aug 25, 2026

Sentiment
10
Attention
2
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The launch expands Humanity's market reach into the U.S., potentially increasing its user base and revenue. For C2N Diagnostics, the partnership adds a novel wellness offering to its consumer platform, potentially driving incremental test sales and strengthening its position in the preventive health market.

Healthcare Diagnostics Wellness

Humanity Health Inc. and C2N Diagnostics announced on August 25, 2026 that Humanity Biological Age, a scientifically validated model for measuring biological age from biomarker lab test results, is now available in the United States for the first time through questhealth.com, Quest's consumer-initiated testing platform. Consumers can add the Humanity Biological Age add-on for $29 when purchasing select health profile tests, including Elite Health Profile, Men's and Women's Comprehensive Health Profiles, and Fitness Profile - Elite, with no additional blood draw needed. After sample collection at one of Quest's approximately 2,000 patient service centers, customers can upload their lab results to Humanity's platform. The report provides a biological age estimate, age difference, trending over time, and identifies which body systems influence the result. Developed with Imperial College London and published in Communications Biology, the model was trained on over 306,000 UK Biobank participants. With this launch, Humanity Biological Age is available in five countries. Pete Ward, CEO of Humanity, and Richard Adams of C2N Diagnostics commented on the launch.

priv
Humanity is the developer and provider of the Biological Age model, and this launch marks its entry into the U.S. market, expanding its commercial footprint and advancing its mission to give a billion years of health back.
Importance 100.0 Sentiment 70.0
priv
C2N Diagnostics is the distribution partner, offering the add-on through its consumer platform and leveraging its network of patient service centers. This enhances Quest's consumer health offerings and may drive additional test volume.
Importance 90.0 Sentiment 60.0
per
Pete Ward is the co-founder and CEO of Humanity, and his leadership is central to the company's strategy and this launch. The event supports his mission to expand access to biological age testing.
Importance 30.0 Sentiment 40.0
per
Richard Adams is the Senior Vice President and General Manager of Consumer at C2N Diagnostics, and his role involves bringing this wellness offering to Quest's consumer platform, aligning with Quest's focus on preventive health.
Importance 20.0 Sentiment 30.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.